- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Caelyx
Total 111 results
-
Janssen Research & Development, LLCPharmaMarCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States, Poland, United Kingdom, China, Switzerland, Israel, South Africa, Australia, Russian Federation, New Zealand
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
Merck Sharp & Dohme LLCMDS Pharma ServicesCompleted
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom
-
University of IowaAventis PharmaceuticalsTerminatedPancreatic CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC...United States
-
SOLTI Breast Cancer Research GroupSchering-PloughCompleted
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Hebei Medical University Fourth HospitalCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCPrincess Margaret Hospital, CanadaCompleted
-
Novo Nordisk A/SCompletedCancer | Ovarian CancerGermany, France
-
AGO Study GroupMerck Sharp & Dohme LLCCompletedCarcinosarcoma | Leiomyosarcoma | Mesenchymal TumorGermany
-
Janssen Research & Development, LLCCompletedNeoplasmsUnited States, Spain, Canada, Belgium
-
Tesaro, Inc.Terminated
-
NHS Greater Glasgow and ClydeBoehringer Ingelheim; Cancer Research UK; European Organisation for Research... and other collaboratorsUnknownOvarian Clear Cell Carcinoma | Endometrial Clear Cell CarcinomaUnited Kingdom
-
North Eastern German Society of Gynaecological...Completed
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Female Reproductive CancerUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedHER-2 Positive Breast Cancer | Malignant Neoplasm of BreastItaly
-
Leiden University Medical CenterUniversity Medical Center GroningenCompleted
-
Xian-Janssen Pharmaceutical Ltd.Terminated
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Janssen Research & Development, LLCCompletedNeoplasms | Neoplasms, Breast | Neoplasms, Ovarian | Advanced or Refractory Solid MalignanciesUnited States, United Kingdom, Spain, Belgium
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
Merck Sharp & Dohme LLCPrincess Margaret Hospital, CanadaCompleted
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
Merck Sharp & Dohme LLCCompletedBreast Neoplasms | Ovarian Neoplasms | Paresthesia
-
Merck Sharp & Dohme LLCTerminated
-
Ludwig Institute for Cancer ResearchJohns Hopkins UniversityWithdrawnSolid Tumors | LymphomasGermany
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedOvarian CancerUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Hong Kong, Taiwan, Spain, Canada, Netherlands, Sweden, Korea, Republic of, Singapore, Russian Federation, Argentina, Brazil, Chile, Australia
-
National Cancer Institute (NCI)CompletedCombination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
ARCAGY/ GINECO GROUPEuropean Organisation for Research and Treatment of Cancer - EORTC; Scherin... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube CancerFrance
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
TelikTerminatedOvarian NeoplasmsUnited States, United Kingdom, Belgium, Brazil
-
WiSP Wissenschaftlicher Service Pharma GmbHClinAssess GmbHUnknown
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
National Cancer Institute (NCI)CompletedAIDS-related Kaposi SarcomaUnited States
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
National Cancer Institute, NaplesWithdrawn